To see if MMP-2 activity was inhibited when co-cultured and non-co-cultured MM cells were treated with bortezomib or bortezomib/lenalidomide/dexamethasone triple treatment, zymography was performed. The gene discussed is MMP2; the disease is Miyoshi myopathy.